Govt allows conditional use of CanSino and Johnson & Johnson 

by S BIRRUNTHA/ pic by AFP

Covid-19 vaccines from China’s CanSino Biologics and the US’ Johnson & Johnson have been given conditional approval for use in Malaysia.

IHealth DG Tan Sri Dr Noor Hisham Abdullah said the decision was made during the 359th Drug Control Authority (DCA) meeting today.

He added that the meeting agreed to grant conditional registration approval for use during an emergency for two vaccine products requiring only one dose of immunisation.

The two vaccines were namely Convidecia Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), produced by CanSino Biologics Inc, China and Johnson & Johnson’s Janssen Covid-19 Vaccine which has been granted Emergency Use Listing (EUL) approval by the World Health Organisation (WHO).

Meanwhile, Dr Noor Hisham said the meeting also approved the usage of Pfizer-BioNTech’s Covid-19 vaccine in the country for those aged 12 years old and above.

He noted that the approval requires information on the quality, safety and effectiveness of the vaccine product, monitored and evaluated based on the latest data from time to time.

“It is to ensure that the comparison of benefit over risk for the vaccine products remains positive,” he said.

However, Dr Noor Hisham added that the MoH is of the view that the priority of vaccination is still to high-risk groups in line with the existing policy set under the National Covid-19 Immunisation Programme (PICK).

Previously, on January 8, Comirnaty was approved conditional registration to be used for the purpose of active immunisation to individuals above 18 years old.